- Home
- VRTS vs ELVN Comparison
VRTS vs ELVN Comparison
Compare VRTS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRTS
- ELVN
- Stock Information
- Founded
- VRTS 1988
- ELVN 2016
- Country
- VRTS United States
- ELVN United States
- Employees
- VRTS N/A
- ELVN N/A
- Industry
- VRTS Investment Managers
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- VRTS Finance
- ELVN Health Care
- Exchange
- VRTS Nasdaq
- ELVN Nasdaq
- Market Cap
- VRTS 1.3B
- ELVN 1.2B
- IPO Year
- VRTS 1992
- ELVN 2020
- Fundamental
- Price
- VRTS $191.60
- ELVN $20.19
- Analyst Decision
- VRTS Hold
- ELVN Strong Buy
- Analyst Count
- VRTS 4
- ELVN 5
- Target Price
- VRTS $190.50
- ELVN $41.20
- AVG Volume (30 Days)
- VRTS 85.4K
- ELVN 563.5K
- Earning Date
- VRTS 10-24-2025
- ELVN 11-12-2025
- Dividend Yield
- VRTS 4.70%
- ELVN N/A
- EPS Growth
- VRTS 37.35
- ELVN N/A
- EPS
- VRTS 20.53
- ELVN N/A
- Revenue
- VRTS $888,980,000.00
- ELVN N/A
- Revenue This Year
- VRTS N/A
- ELVN N/A
- Revenue Next Year
- VRTS $1.36
- ELVN $20.05
- P/E Ratio
- VRTS $9.33
- ELVN N/A
- Revenue Growth
- VRTS 0.99
- ELVN N/A
- 52 Week Low
- VRTS $142.18
- ELVN $13.30
- 52 Week High
- VRTS $252.82
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- VRTS 48.11
- ELVN 52.19
- Support Level
- VRTS $184.70
- ELVN $19.02
- Resistance Level
- VRTS $195.00
- ELVN $20.66
- Average True Range (ATR)
- VRTS 4.11
- ELVN 1.04
- MACD
- VRTS 0.05
- ELVN 0.10
- Stochastic Oscillator
- VRTS 60.00
- ELVN 71.76
About VRTS Virtus Investment Partners Inc.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.